In this interview, David Engel from Full Moon Investments in the U.S., charts the firm’s successful targeted investment strategy – informed by industry-leading experience and expertise – including comments on the CBD hemp and medical cannabis space.
No posts to display
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders